JPRN-jRCT2080221994未知2 期
An Exploratory Study for AD-810N in Patients with Parkinsonism in Dementia with Lewy Bodies (Phase 2 study)
试验速览
- 阶段
- 2 期
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 84age old（—）
- 性别
- All
入选标准
- •Patients met the diagnostic criteria of probable DLB
- •-Outpatients
- •-Patients taking L-DOPADCI in succession more than 12 weeks
排除标准
- •-Patients with parkinsonism excepting Dementia with Lewy Bodies
- •-Patients with Parkinson's disease with dementia
- •-Epileptic patients
- •-Patients treated with zonisamide
研究者
相似试验
未知
3 期
Confirmatory Study for AD-810N in Patients with Parkinsonism in Dementia with Lewy Bodies.JPRN-jRCT2080222787Sumitomo Dainippon Pharma Co., Ltd.300
未知
3 期
A double-blind confirmatory study for AD-810N (zonisamide) in patients with Parkinson's disease (Phase III)Parkinson's diseaseJPRN-jRCT2080221162Dainippon Sumitomo Pharma Co., Ltd.360
进行中（未招募）
1 期
A Phase 1 and 2 Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of AZD8233 Following a Multiple Subcutaneous Dose Administration in Japanese Participants With DyslipidemiaDyslipidemiaJPRN-jRCT2051210041Hibi Kazushige91
已完成
1 期
An Exploratory Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infection (COVID-19)Patients with Severe Pneumonia caused by SARS-CoV-2 infectionJPRN-jRCT1080225320ROHTO PHARMACEUTICAL CO., LTD.6
招募中
2 期
A Phase 2 Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infectioPatients with Severe Pneumonia caused by SARS-CoV-2 infectionJPRN-jRCT2053210023Okawa Sumito20